Paul A Dawson1. 1. Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Emory University School of Medicine, Atlanta, Ga., USA.
Abstract
BACKGROUND: In addition to their classical role as detergents, bile acids function as signaling molecules to regulate gastrointestinal physiology, carbohydrate and lipid metabolism, and energy expenditure. The pharmacodynamic potential of bile acids is dependent in part on the tight pharmacokinetic control of their concentration and metabolism, properties governed by their hepatic synthesis, enterohepatic cycling, and biotransformation via host and gut microbiota-catalyzed pathways. Key Messages: By altering the normal cycling and compartmentalization of bile acids, changes in hepatobiliary or intestinal transport can affect signaling and lead to the retention of cytotoxic hydrophobic bile acids and cell injury. This review discusses advances in our understanding of the intestinal transporters that maintain the enterohepatic cycling of bile acids, signaling via bile acid-activated nuclear and G protein receptors, and mechanisms of bile acid-induced cell injury. CONCLUSIONS: Dysregulated expression of the Asbt and Ostα-Ostβ alters bile acid signaling via the gut-liver farnesoid X receptor-fibroblast growth factor 15/19 axis and may contribute to other bile acid-regulated metabolic and cell injury pathways.
BACKGROUND: In addition to their classical role as detergents, bile acids function as signaling molecules to regulate gastrointestinal physiology, carbohydrate and lipid metabolism, and energy expenditure. The pharmacodynamic potential of bile acids is dependent in part on the tight pharmacokinetic control of their concentration and metabolism, properties governed by their hepatic synthesis, enterohepatic cycling, and biotransformation via host and gut microbiota-catalyzed pathways. Key Messages: By altering the normal cycling and compartmentalization of bile acids, changes in hepatobiliary or intestinal transport can affect signaling and lead to the retention of cytotoxic hydrophobic bile acids and cell injury. This review discusses advances in our understanding of the intestinal transporters that maintain the enterohepatic cycling of bile acids, signaling via bile acid-activated nuclear and G protein receptors, and mechanisms of bile acid-induced cell injury. CONCLUSIONS: Dysregulated expression of the Asbt and Ostα-Ostβ alters bile acid signaling via the gut-liver farnesoid X receptor-fibroblast growth factor 15/19 axis and may contribute to other bile acid-regulated metabolic and cell injury pathways.
Authors: Matthew J Potthoff; Austin Potts; Tianteng He; João A G Duarte; Ronald Taussig; David J Mangelsdorf; Steven A Kliewer; Shawn C Burgess Journal: Am J Physiol Gastrointest Liver Physiol Date: 2012-12-20 Impact factor: 4.052
Authors: Anuradha Rao; Jamie Haywood; Ann L Craddock; Martin G Belinsky; Gary D Kruh; Paul A Dawson Journal: Proc Natl Acad Sci U S A Date: 2008-02-21 Impact factor: 11.205
Authors: O S Popović; K M Kostić; V B Milović; S Milutinović-Djurić; V D Miletić; L Sesić; M Djordjević; M Bulajić; P Bojić; M Rubinić Journal: Gastroenterology Date: 1987-06 Impact factor: 22.682
Authors: Sunder Mudaliar; Robert R Henry; Arun J Sanyal; Linda Morrow; Hanns-Ulrich Marschall; Mark Kipnes; Luciano Adorini; Cathi I Sciacca; Paul Clopton; Erin Castelloe; Paul Dillon; Mark Pruzanski; David Shapiro Journal: Gastroenterology Date: 2013-05-30 Impact factor: 22.682
Authors: Serkan Kir; Sara A Beddow; Varman T Samuel; Paul Miller; Stephen F Previs; Kelly Suino-Powell; H Eric Xu; Gerald I Shulman; Steven A Kliewer; David J Mangelsdorf Journal: Science Date: 2011-03-25 Impact factor: 47.728
Authors: Martina Düfer; Katrin Hörth; Rebecca Wagner; Björn Schittenhelm; Susanne Prowald; Thomas F J Wagner; Johannes Oberwinkler; Robert Lukowski; Frank J Gonzalez; Peter Krippeit-Drews; Gisela Drews Journal: Diabetes Date: 2012-04-09 Impact factor: 9.461
Authors: Ivo P van de Peppel; Anna Bertolini; Theo H van Dijk; Albert K Groen; Johan W Jonker; Henkjan J Verkade Journal: J Lipid Res Date: 2019-07-19 Impact factor: 5.922
Authors: Mohammed Nabil Quraishi; Animesh Acharjee; Andrew D Beggs; Richard Horniblow; Chris Tselepis; Georgios Gkoutos; Subrata Ghosh; A E Rossiter; Nicholas Loman; Willem van Schaik; David Withers; Julian R F Walters; Gideon M Hirschfield; Tariq H Iqbal Journal: J Crohns Colitis Date: 2020-07-30 Impact factor: 9.071
Authors: Rune Rose Tronstad; Siren Berland; Erling Tjora; Khadija El Jellas; Ingvild Aukrust; Kurt Kristensen; Dag Tveitnes; Anders Molven; Hanns-Ulrich Marschall; Anuradha Rao; Paul A Dawson Journal: JPGN Rep Date: 2022-07-25